Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului
Yüklə 4,39 Mb.
|
| Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ G04CB02 DUTASTERIDUM CAPS. MOI 0.5 mg AVODART(R) 0.5 mg GLAXO GROUP LTD.
| 281 |H01AA02| TETRACOSACTIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H01AA02 TETRACOSACTIDUM SUSP. INJ. 1 mg/ml SYNACHTEN DEPOT 1 mg/ml NOVARTIS PHARMA GMBH
| 282 |H01AC01| SOMATROPINUM***# | Protocol: H009E | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H01AC01 SOMATROPINUM SOL. INJ. 10 mg/1.5 ml NORDITROPIN 10 mg/1.5 ml NOVO NORD ISK A/S SIMPLEX x 10 mg/1,5 ml H01AC01 SOMATROPINUM SOL. INJ. 10 mg/2 ml NUTROPINAq 10 mg/2 ml 10 mg/2 ml IPSEN LIMITED H01AC01 SOMATROPINUM SOL. INJ. 3,3 mg/ml OMNITROPE 3,3 mg/ml 3,3 mg/ml SANDOZ GMBH H01AC01 SOMATROPINUM LIOF. + SOLV. PT. SOL. 4 mg (12 ui) INJ.
ZOMACTON 4 mg (12 ui) FERING GMBH H01AC01 SOMATROPINUM PULB. + SOLV. PT. SOL. 5.3 mg/ml (16 ui) INJ.
GENOTROPIN(R) 16 ui (5,3 mg) 5.3 mg/ml (16 ui) PFIZER EUROPE MA EEIG H01AC01 SOMATROPINUM SOL. INJ. 5 mg/1.5 ml NORDITROPIN 5 mg/1.5 ml NOVO NORDISK A/S SIMPLEX x 5 mg/1,5 ml
| 283 |H01CC01| GANIRELIXUM***# | Protocol: G004N | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H01CC01 GANIRELIXUM SOL. INJ. 0.25 mg/0.5 ml ORGALUTRAN 0.25 mg/0.5 ml 0.25 mg/0.5 ml N.V. ORGANON
| 284 |H01CC02| CETRORELIXUM***# | Protocol: H004E | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H01CC02 CETRORELIXUM LIOF. + SOLV. PT. SOL. 0.25 mg INJ. CETROTIDE 0,25 mg 0.25 mg SERONO EUROPE LTD. H01CC02 CETRORELIXUM LIOF. + SOLV. PT. SOL. 3 mg INJ.
CETROTIDE 3 mg 3 mg SERONO EUROPE LTD. ______________________________________________________________________________ | 285 |H02AA02| FLUDROCORTISONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H02AA02 FLUDROCORTISONUM COMPR. 0.1 mg ASTONIN H 0.1 mg MERCK KGAA
| 286 |H02AB01| BETAMETHASONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H02AB01 BETAMETHASONUM SUSP. INJ. I.M. 7 mg/ml DIPROPHOS(R) 7 mg/ml SCHERING PLOUGH EUROPE
| 287 |H02AB06| PREDNISOLONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. 250 mg INJ. SOLU-DECORTIN H 250 250 mg MERCK KGAA H02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. 50 mg INJ.
SOLU-DECORTIN H 50 50 mg MERCK KGAA ______________________________________________________________________________ | 288 |H03BB02| THIAMAZOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H03BB02 THIAMAZOLUM COMPR. FILM. 10 mg THYROZOL(R) 10 mg 10 mg MERCK KGAA
THYROZOL(R) 20 mg 20 mg MERCK KGAA H03BB02 THIAMAZOLUM COMPR. FILM. 5 mg THYROZOL(R) 5 mg 5 mg MERCK KGAA ______________________________________________________________________________ | 289 |H05BA01| CALCITONINUM (SOMON) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H05BA01 CALCITONINUM (SOMON) SOL. INJ. 100 UI TONOCALCIN 100 UI 100 UI ALFA WASSERMANN SPA
NYLEX 100 Ul/doza 100 UI/doza PHARMACEUTICAL IND. PROEL EPAM. G. CORONIS SA
NYLEX(R) 100 UI/ml PROEL E.P. CORONIS SA H05BA01 CALCITONINUM (SOMON) SPRAY NAZAL-SOL. 200 UI/doza MIACALCIC(R) NASAL 200 200 ui/doza NOVARTIS PHARMA GMBH NYLEX(R) 200 UI/doza PROEL E.P. CORONIS SA
MIACALCIC(R) 50 ui/ml NOVARTIS PHARMA GMBH ______________________________________________________________________________ | 290 |J01CR01| AMPICILLINUM + SULBACTAM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01CR01 AMPICILLINUM + PULB. PT. SOL. INJ. 1 g + 500 mg SULBACTAM AMPIPLUS(R) 1,5 g 1 g + 500 mg ANTIBIOTICE SA ______________________________________________________________________________ | 291 |J01CR04| SULTAMICILLINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01CR04 SULTAMICILLINUM PULB. PT. SUSP. ORALĂ 250 mg/5 ml UNASYN 250 mg/5 ml PFIZER EUROPE MA EEIG
UNASYN 375 mg PFIZER EUROPE MA EEIG ______________________________________________________________________________ | 292 |J01DC10| CEFPROZILUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01DC10 CEFPROZILUM PULB. PT. SUSP. ORALĂ 125 mg/5 ml CEFZIL 125 mg/5 ml 125 mg/5 ml BRISTOL-MYERS SQUIBB KFT.
CEFZIL 250 mg 250 mg BRISTOL-MYERS SQUIBB KFT. J01DC10 CEFPROZILUM PULB. PT. SUSP. ORALĂ 250 mg/5 ml CEFZIL 250 mg/5 ml 250 mg/5 ml BRISTOL-MYERS SQUIBB KFT. J01DC10 CEFPROZILUM COMPR. FILM. 500 mg CEFZIL 500 mg 500 mg BRISTOL-MYERS SQUIBB KFT. ______________________________________________________________________________ | 293 |J01DD14| CEFTIBUTENUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01DD14 CEFTIBUTENUM PULB. PT. SUSP. ORALĂ 36 mg/ml CEDAX 36 mg/ml SCHERING PLOUGH EUROPE
CEDAX 400 mg SCHERING PLOUGH EUROPE ______________________________________________________________________________ | 294 |J01FA02| SPIRAMYCINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01FA02 SPIRAMYCINUM COMPR. FILM. 1.5 M ui ROVAMYCINE(R) 1,5 Mil. UI 1.5 M ui LAB. AVENTIS
ROVAMYCINE(R) 3 Mil. UI 3 M ui LAB. AVENTIS ________________________________________________________________________________
| 295 |J01FA10| AZITHROMYCINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALĂ 100 mg/5 ml AZITROMICINA 100 mg/5 ml SANDOZ SRL SANDOZ 100 mg/5 ml J01FA10 AZITHROMYCINUM COMPR. FILM. 125 mg SUMAMED 125 mg 125 mg PLIVA LJUBLJANA D.O.O. J01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALĂ 200 mg/5 ml AZITROMICINA 200 mg/5 ml SANDOZ SRL SANDOZ 200 mg/5 ml
ORALĂ
AZITROX 200 mg/5 ml 200 mg/5 ml ECZACIBASI PHARMACEUTICALS S.R.L.
SUMAMED FORTE 200 mg/5 ml PLIVA LJUBLIJANA D.O.O.
AZATRIL 250 mg 250 mg BALKANPHARMA RAZGRAD AD J01FA10 AZITHROMYCINUM COMPR. FILM. 250 mg AZITROMICINA SANDOZ 250 mg 250 mg SANDOZ S.R.L. COMPRIMATE FILMATE AZITROX(R) 250 250 mg ZENTIVA AS J01FA10 AZITHROMYCINUM COMPR. FILM. 500 mg AZITROMICINA SANDOZ 500 mg 500 mg SANDOZ S.R.L. COMPRIMATE FILMATE AZITROX(R) 500 500 mg ZENTIVA AS AZRO(R) 500 mg 500 mg ECZACIBASI PHARMACEUTICALS S.R.L.
SUMAMED 500 mg 500 mg PLIVA LJUBLJANA D.O.O. ZITROCIN 500 mg 500 mg OZONE LABORATORIES LTD. J01FA10 AZITHROMYCINUM GRAN. ELIB. PREL. PT. 2 g SUSP. ORALĂ ZMAX 2 g 2 g PFIZER EUROPE MA EEIG ________________________________________________________________________________ ______________________________________________________________________________ | 296 |J01FF01| CLINDAMYCINUM | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|